Evidence map›Paper›PMID 36377205›Full record

SynthesisJournal of biological rhythms2023

Chronotype in Patients With Immune-Mediated Inflammatory Disease: A Systematic Review.

Thomas D Butler, Aala Mohammed Ali, Julie E Gibbs, John T McLaughlin

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Journal of biological rhythms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Individual associations of self-reported sleep duration, sleep quality, chronotype and social jet lag with infectious disease risk.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Thomas D ButlerCentre for Biological Timing, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.ORCID 0000-0003-0918-6713
Aala Mohammed AliDivision of Diabetes, Endocrinology and Gastroenterology, The University of Manchester, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Julie E GibbsCentre for Biological Timing, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
John T McLaughlinDivision of Diabetes, Endocrinology and Gastroenterology, The University of Manchester, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Manchester Academic Health Science Centre · GBUniversity of Manchester · GB

Funding

Medical Research Council MR/P023576/1Medical Research Council MR/P023576/2Medical Research Council MR/S002715/1Medical Research Council MR/S02199X/1Wellcome Trust 107851/Z/15/Z
6 · The paper itself

Abstract

Immune-mediated inflammatory diseases (IMIDs) such as rheumatoid arthritis, inflammatory bowel disease, and asthma share common pathophysiological pathways characterized by chronic inflammation and subsequent tissue damage involving multiple body sites. Circadian rhythms are 24-h body cycles that regulate immune activity and control the magnitude of immune response based on time of day. Chronotype is a person's individual circadian phase preference, ranging from morningness to eveningness, which is known to influence the risk of cardiometabolic and mental health disease. We systematically reviewed the literature to assess the association of questionnaire-based chronotype and patients with IMID. A comprehensive search of MEDLINE and Embase identified 12 studies meeting the inclusion criteria, conducted in 7 countries and covering 4 IMIDs to include 15,625 IMID patients and 410,783 healthy controls. Results showed that later chronotype may be a risk factor for worse quality of life and increased symptom burden in patients with IMIDs. In addition, chronotype may be a risk factor for IMID incidence, but the direction and magnitude of this effect were not consistent across individual IMIDs. Chronotype assessment could contribute to risk stratification in patients with IMIDs. Cross-disciplinary collaboration to understand the role of circadian rhythms and chronotype in driving common inflammatory pathways could help to improve outcomes for patients with IMIDs.

Indexed as

ChronotypeCircadian RhythmHumansImmunomodulating AgentsInflammationQuality of LifeSleepSurveys and QuestionnairesImmunomodulating Agentschronotypecircadianimmune-mediated inflammatory diseaseinflammationsystematic review

Identifiers

PMID36377205
PMCPMC9902971
OpenAlexW4309223693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.